- Home
- SERA vs INGN Comparison
SERA vs INGN Comparison
Compare SERA & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- INGN
- Stock Information
- Founded
- SERA 2008
- INGN 2001
- Country
- SERA United States
- INGN United States
- Employees
- SERA N/A
- INGN N/A
- Industry
- SERA Precision Instruments
- INGN Industrial Specialties
- Sector
- SERA Health Care
- INGN Health Care
- Exchange
- SERA Nasdaq
- INGN Nasdaq
- Market Cap
- SERA 70.4M
- INGN N/A
- IPO Year
- SERA 2021
- INGN 2014
- Fundamental
- Price
- SERA $2.49
- INGN $7.49
- Analyst Decision
- SERA
- INGN Strong Buy
- Analyst Count
- SERA 0
- INGN 3
- Target Price
- SERA N/A
- INGN $11.00
- AVG Volume (30 Days)
- SERA 806.3K
- INGN 205.7K
- Earning Date
- SERA 08-06-2025
- INGN 08-05-2025
- Dividend Yield
- SERA N/A
- INGN N/A
- EPS Growth
- SERA N/A
- INGN N/A
- EPS
- SERA N/A
- INGN N/A
- Revenue
- SERA $115,000.00
- INGN $339,960,000.00
- Revenue This Year
- SERA $390.13
- INGN $7.46
- Revenue Next Year
- SERA $440.54
- INGN $6.03
- P/E Ratio
- SERA N/A
- INGN N/A
- Revenue Growth
- SERA N/A
- INGN 5.73
- 52 Week Low
- SERA $1.37
- INGN $5.70
- 52 Week High
- SERA $9.13
- INGN $13.33
- Technical
- Relative Strength Index (RSI)
- SERA 53.89
- INGN 68.13
- Support Level
- SERA $1.82
- INGN $6.86
- Resistance Level
- SERA $4.09
- INGN $7.30
- Average True Range (ATR)
- SERA 0.36
- INGN 0.33
- MACD
- SERA 0.10
- INGN 0.09
- Stochastic Oscillator
- SERA 35.74
- INGN 92.54
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.